{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:42:29Z","timestamp":1790944949959,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2010,2,9]]},"DOI":"10.1212\/wnl.0b013e3181cef7e3","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T21:43:23Z","timestamp":1265665403000},"page":"487-493","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":134,"title":["<sup>11<\/sup>\n            C-PIB binding is increased in patients with cerebral amyloid angiopathy\u2013related hemorrhage"],"prefix":"10.1212","volume":"74","author":[{"given":"J. V.","family":"Ly","sequence":"first","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Donnan","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. L.","family":"Villemagne","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Zavala","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ma","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"O'Keefe","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Gong","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Gunawan","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Saunder","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Ackerman","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tochon-Danguy","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Churilov","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. G.","family":"Phan","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Rowe","sequence":"additional","affiliation":[{"name":"From the National Stroke Research Institute (J.V.L., G.A.D., J.A.Z., H.M., R.M.G., L.C.), University of Melbourne, Austin Health, Heidelberg Heights; Department of Nuclear Medicine (V.L.V., G.O., S.J.G., T.S., U.A., H.T.-D., C.C.R.), Centre for PET, Austin Health, Heidelberg; and Department of Neurosciences (T.G.P.), Monash Medical Centre, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","first-page":"11","volume":"44","year":"1997","unstructured":"Itoh Y, Yamada M. Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. J Med Dent Sci 1997;44:11\u201319.","journal-title":"J Med Dent Sci"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.8.1333"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380219"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm030026b"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl178"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000261919.22630.ea"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21164"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000126807.69758.0e"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610204000390"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1109\/42.538946"},{"key":"e_1_3_3_14_2","first-page":"1959","volume":"46","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, et al. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 2005;46:1959\u20131972.","journal-title":"J Nucl Med"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600146"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199609000-00008"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.537"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20596"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000194266.55694.1e"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.3.431"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1981.tb01757.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.6.924"},{"key":"e_1_3_3_23_2","first-page":"120","year":"1981","unstructured":"Glenner GG, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981;1:120\u2013129.","journal-title":"Ann Pathol"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(93)90693-F"},{"key":"e_1_3_3_25_2","first-page":"179","year":"1996","unstructured":"Vinters HV, Wang ZZ, Secor DL. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996;6:179\u2013195.","journal-title":"Brain Pathol"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.5.625"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.18.2.311"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00856809"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.6.1592"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.6.790"},{"key":"e_1_3_3_31_2","first-page":"37","year":"2005","unstructured":"Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 2005;229\u2013230:37\u201341.","journal-title":"J Neurol Sci"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.11.1629"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.11.2109"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-1-17"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199209000-00025"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00825-7"},{"key":"e_1_3_3_38_2","first-page":"210","volume":"29","year":"1991","unstructured":"Pendlebury WW, Iole ED, Tracy RP, Dill BA. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann Intern Med 1991;29:210\u2013213.","journal-title":"Ann Intern Med"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100030705"},{"key":"e_1_3_3_40_2","first-page":"28","volume":"8","year":"2001","unstructured":"Gervais F, Chalifour R, Garceau D, et al. Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy. Amyloid 2001;8(suppl 1):28\u201335.","journal-title":"Amyloid"},{"key":"e_1_3_3_41_2","first-page":"269","year":"2006","unstructured":"Greenberg SM, Rosand J, Schneider AT, et al. A phase 2 study of tramiprosate for cerebral amyloid angiopathy. Alzheimer Dis Assoc Disord 2006;20:269\u2013274.","journal-title":"Alzheimer Dis Assoc Disord"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3181cef7e3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:55:46Z","timestamp":1711551346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3181cef7e3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,2,9]]}},"alternative-id":["10.1212\/WNL.0b013e3181cef7e3"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3181cef7e3","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}